Teva, Bausch & Lomb receive tentative ANDA approval for generic versions of Rogaine..
This article was originally published in The Tan Sheet
TEVA, BAUSCH & LOMB RECEIVE TENTATIVE APPROVAL TO MARKET GENERIC ROGAINE beginning on Feb. 13, when Pharmacia & Upjohn's patent for the topical minoxidil 2% hair loss treatment expires. Teva's generic subsidiary Lemmon received the first tentative ANDA approval for topical minoxidil on Dec. 15; Bausch & Lomb Pharmaceuticals received tentative approval on Dec. 22.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC